HL-02613/HL/NHLBI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1997	2
1998	3
1999	1
2001	2
2002	2
2022	0

1

Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension.

Preston IR, Klinger JR, Landzberg MJ, Houtchens J, Nelson D, Hill NS. Preston IR, et al. Chest. 2001 Sep;120(3):866-72. doi: 10.1378/chest.120.3.866. Chest. 2001. PMID: 11555522

2

Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.

Hill NS, Warburton RR, Pietras L, Klinger JR. Hill NS, et al. J Appl Physiol (1985). 1997 Oct;83(4):1209-15. doi: 10.1152/jappl.1997.83.4.1209. J Appl Physiol (1985). 1997. PMID: 9338430 Free article.

3

Brain natriuretic peptide inhibits hypoxic pulmonary hypertension in rats.

Klinger JR, Warburton RR, Pietras L, Hill NS. Klinger JR, et al. J Appl Physiol (1985). 1998 May;84(5):1646-52. doi: 10.1152/jappl.1998.84.5.1646. J Appl Physiol (1985). 1998. PMID: 9572812 Free article.

4

C-type natriuretic peptide expression and pulmonary vasodilation in hypoxia-adapted rats.

Klinger JR, Siddiq FM, Swift RA, Jackson C, Pietras L, Warburton RR, Alia C, Hill NS. Klinger JR, et al. Am J Physiol. 1998 Oct;275(4):L645-52. doi: 10.1152/ajplung.1998.275.4.L645. Am J Physiol. 1998. PMID: 9755096

5

Targeted disruption of the gene for natriuretic peptide receptor-A worsens hypoxia-induced cardiac hypertrophy.

Klinger JR, Warburton RR, Pietras L, Oliver P, Fox J, Smithies O, Hill NS. Klinger JR, et al. Am J Physiol Heart Circ Physiol. 2002 Jan;282(1):H58-65. doi: 10.1152/ajpheart.2002.282.1.H58. Am J Physiol Heart Circ Physiol. 2002. PMID: 11748047 Free article.

6

Genetic disruption of atrial natriuretic peptide causes pulmonary hypertension in normoxic and hypoxic mice.

Klinger JR, Warburton RR, Pietras LA, Smithies O, Swift R, Hill NS. Klinger JR, et al. Am J Physiol. 1999 May;276(5):L868-74. doi: 10.1152/ajplung.1999.276.5.L868. Am J Physiol. 1999. PMID: 10330043

7

Pulmonary edema caused by inhaled nitric oxide therapy in two patients with pulmonary hypertension associated with the CREST syndrome.

Preston IR, Klinger JR, Houtchens J, Nelson D, Mehta S, Hill NS. Preston IR, et al. Chest. 2002 Feb;121(2):656-9. doi: 10.1378/chest.121.2.656. Chest. 2002. PMID: 11834688

8

Atrial natriuretic peptide expression in rats with different pulmonary hypertensive responses to hypoxia.

Klinger JR, Wrenn DS, Warburton RR, Pietras L, Ou LC, Hill NS. Klinger JR, et al. Am J Physiol. 1997 Jul;273(1 Pt 2):H411-7. doi: 10.1152/ajpheart.1997.273.1.H411. Am J Physiol. 1997. PMID: 9249516

9

Reduced oxygen tension increases atrial natriuretic peptide release from atrial cardiocytes.

Klinger JR, Pietras L, Warburton R, Hill NS. Klinger JR, et al. Exp Biol Med (Maywood). 2001 Oct;226(9):847-53. doi: 10.1177/153537020122600907. Exp Biol Med (Maywood). 2001. PMID: 11568308

10

Exaggerated pulmonary hypertensive responses during chronic hypoxia in mice with gene-targeted reductions in atrial natriuretic peptide.

Klinger JR, Warburton RR, Pietras LA, Swift R, John S, Hill NS. Klinger JR, et al. Chest. 1998 Jul;114(1 Suppl):79S-80S. doi: 10.1378/chest.114.1_supplement.79s. Chest. 1998. PMID: 9676645 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results